跳到主要內容

Vivo Capital Fund VIII, L.P. 的 Form 4 申報

Terns Pharmaceuticals, Inc.TERN,2022/8/16 申報

申報編號
0001213900-22-048763
申報時間
2022/8/16 20:44 ET
交易日
2022/8/12-8/16
申報延遲
4 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 3 筆非衍生性交易、1 筆衍生性交易。公開市場買進合計 $698.0 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Vivo Capital Fund VIII, L.P.CIK 0001618788持股 10% 以上大股東
Vivo Capital VIII, LLCCIK 0001618789持股 10% 以上大股東
Vivo Capital Surplus Fund VIII, L.P.CIK 0001628048持股 10% 以上大股東
Vivo Opportunity, LLCCIK 0001728970持股 10% 以上大股東
Vivo Opportunity Fund Holdings, L.P.CIK 0001930214持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/8/12Common StockP買進取得+1,123,021$2.98F2+$3,346,602.581,480,374間接重複申報
2022/8/15Common StockP買進取得+1,218$2.99F3+$3,641.821,481,592間接重複申報
2022/8/16Common StockP買進取得+1,500,000$2.42F4+$3,630,0002,981,592間接重複申報

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2022/8/16Common StockP買進取得+1,500,000$2.42+$3,629,8501,500,000間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $2.83 to $3.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (2) to this Form 4.

表 I 有 1 筆交易的價格引用這則附註。

F3

The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $2.96 to $3.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (3) to this Form 4.

表 I 有 1 筆交易的價格引用這則附註。

F4

The reporting person acquired 1,500,000 shares of Common Stock at $2.42 per share and 1,500,000 pre-funded warrants at $2.41990 per warrant in an underwritten offering.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)